Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahea - The Economic Times

Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahea  The Economic TimesOzempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight  BBCNatco launches Rs 1,290 semaglutide in India, undercuts diabetes drug prices  The Economic TimesSemaglutide’s patent expires today. What does it mean for patients, pharma players and Novo Nordisk?  Moneycontrol.comOzempic Is About to Go Generic in India, China and Canada  The New York Times